ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CMII CM Life Sciences II Inc

10.63
0.00 (0.00%)
07 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
CM Life Sciences II Inc NASDAQ:CMII NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 10.63 10.26 11.61 0 01:00:00

Withdrawal of Registration Statement (ammendment) (aw)

01/05/2023 11:05am

Edgar (US Regulatory)


 

April 28, 2023

 

VIA EMAIL AND EDGAR

U.S. Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549

 

Re:SomaLogic, Inc.

Request for Withdrawal of Post-Effective Amendment No. 4 to Form S-1

Filed March 29, 2023 (SEC Accession No. 23771555/Commission File No. 333-259954)

 

Dear Sir or Madam:

On March 29, 2023, SomaLogic, Inc. (the “Company”) filed Post-Effective Amendment No. 4 to Form S-1 (Commission File No. 333-259954) (the “Post-Effective Amendment”) with the Securities and Exchange Commission (the “Commission”). At the Commission’s request and pursuant to Rule 477 under the Securities Act of 1933, as amended, the Company respectfully requests the immediate withdrawal of the Post-Effective Amendment and respectfully requests that the Commission consent thereto. Because the Post-Effective Amendment was not declared effective by the Commission, no offers or sales were made pursuant to the Post-Effective Amendment.

 


Thank you for your assistance in this request. If you have any questions regarding this letter or require any additional information, please do not hesitate to contact, by a telephone call or email, the Company’s counsel, Tyler F. Mark of Bryan Cave Leighton Paisner LLP, who can be reached at (303) 866-0238 or
Tyler.Mark@bclplaw.com.


Thank you.

 

  Very truly yours,
   
  SOMALOGIC, INC.
   
  By:  /s/ Ruben Gutierrez
    Name: Ruben Gutierrez
Title: General Counsel

  

cc:Charles D. Maguire, Jr.
  Tyler F. Mark
  Bryan Cave Leighton Paisner LLP

 

 

 

1 Year CM Life Sciences II Chart

1 Year CM Life Sciences II Chart

1 Month CM Life Sciences II Chart

1 Month CM Life Sciences II Chart